Benchmark Maintains Speculative Buy on Milestone Scientific, Lowers Price Target to $1
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Benchmark analyst Bruce D. Jackson maintains Milestone Scientific (AMEX:MLSS) with a Speculative Buy and lowers the price target from $1.25 to $1.
Benchmark analyst Bruce D. Jackson maintains Milestone Scientific (AMEX:MLSS) with a Speculative Buy and lowers the price target from $1.25 to $1.